Compare General Mills, Inc. (GIS) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Mills, Inc. vs Tenet Healthcare Corporation — how do they compare? General Mills, Inc. trades at $32.32 (market cap $16.99B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and General Mills, Inc. pays a 7.68% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Mills, Inc. for 106 Days and Tenet Healthcare Corporation for 15 Days on average.
| GIS | THC | |
|---|---|---|
Market Cap | $16.99B | $20.92B |
Volume | 10,265,203 | 455,764 |
Sector | Consumer Staples | Health |
52-Week High | $49.36 | $280.77 |
52-Week Low | $31.67 | $161.37 |
Typical Hold Time | 106 Days | 15 Days |
Enterprise Value | $30.17B | $32.00B |
Dividend Yield | 7.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Mills (GIS) trades at $31.77, down 1.27% on the day, with a bearish technical signal and mixed earnings performance. The stock shows attractive valuation ratios like a P/E of 9.23 and P/S of 0.93, but profitability metrics are weak with a negative net income margin and ROE. Recent news highlights a CEO transition and a 22% stock decline last month amid revenue and profit pressures.
The outlook is cautious; while the dividend yield is appealing and cost-saving initiatives are in place, declining revenue, margin compression, and high debt levels pose significant risks. Analyst consensus is mixed with a $36 price target, but bearish sentiment and competitive pressures suggest limited near-term upside.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
